In agreement with this, E2F6 possibly targets different gene promoters in each of the studied normal and cancer cell lines; this needs to be extensively investigated using chromatin immunoprecipitation for further confirmation of this idea, at least in breast cancer. Here, E2F6 is linked to cancer.